Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Pediatr Blood Cancer. 2010 Feb;54(2):242–249. doi: 10.1002/pbc.22308

Table I.

Birth characteristics of controls and children with any cancer cases and by cancer subtypea

Controls (n = 13331) Total Cases (n = 2552) Total leukemia (n = 913) ALLa (n = 727) AMLa (n = 124) CNSa (n = 438)
N (%) N (%) N (%) N (%) N (%) N (%)
Sex
Male 6788 (50.9) 1444 (56.6) 524 (57.4) 409 (56.3) 76 (61.3) 253 (57.8)
Female 6543 (49.1) 1108 (43.4) 389 (42.6) 318 (43.7) 48 (38.7) 185 (42.2)
  Pb <0.0001 0.0002 0.0050 0.0215 0.0048

Ethnicity
 White 5431 (40.7) 1180 (46.2) 387 (42.4) 322 (44.3) 45 (36.3) 234 (53.4)
 Black 1568 (11.8) 224 (8.8) 63 (6.9) 34 (4.7) 19 (15.3) 48 (11.0)
Hispanic 5931 (44.5) 1092 (42.8) 442 (48.4) 355 (48.8) 55 (44.4) 152 (34.7)
Other 401 (3.0) 56 (2.2) 21 (2.3) 16 (2.2) 5 (4.0) 4 (0.9)
  P <0.0001 <0.0001 <0.0001 0.5038 <0.0001

Maternal age (years)
Mean (SDa) 26.0 (6.1) 26.5 (6.2) 26.8 (6.3) 26.7 (6.1) 27.6 (7.3) 25.8 (6.0)
Range 13–55 13–48
  P <0.0001 <0.0001 0.0007 0.0139 0.6001
< 35 12066 (90.5) 2271 (89.0) 799 (87.5) 645 (88.7) 97 (78.2) 401 (91.5)
≥ 35 1265 (9.5) 281 (11.0) 114 (12.5) 82 (11.3) 27 (21.8) 37 (8.5)
  P 0.0175 0.0030 0.1103 <0.0001 0.4635

Paternal age (years)
Mean (SD) 29.0 (6.8) 29.5 (6.9) 29.8 (7.1) 29.8 (7.0) 30.9 (7.6) 29.1 (6.9)
Range (14–70) (15–62)
  P 0.0036 0.0022 0.0049 0.0061 0.8194
< 35 8971 (67.3) 1703 (66.7) 590 (64.6) 480 (66.0) 64 (51.6) 304 (69.4)
≥ 35 2293 (17.2) 517 (20.3) 207 (22.7) 160 (22.0) 39 (31.5) 79 (18.0)
Missing 2067 (15.5) 332 (13.0) 116 (12.7) 87 (12.0) 21 (16.9) 55 (12.6)
  P <0.0001 <0.0001 0.0006 <0.0001 0.2412

Gestational age (weeks)
< 37 1301 (9.8) 253 (9.9) 83 (9.1) 65 (8.9) 15 (12.1) 40 (9.1)
37–41 9408 (70.6) 1829 (71.7) 661 (72.4) 523 (71.9) 88 (80.0) 299 (68.3)
≥ 42 1574 (11.8) 261 (10.2) 99 (10.8) 81 (11.1) 13 (10.5) 58 (13.2)
Missing 1048 (7.9) 209 (8.2) 70 (7.7) 58 (8.0) 8 (6.4) 41 (9.4)
  P 0.1488 0.6793 0.8185 0.7572 0.4874

Weight corrected for gestational age
SGA 1343 (10.1) 235 (9.2) 72 (7.9) 49 (6.7) 14 (11.3) 44 (10.1)
AGA 9212 (69.1) 1754 (68.7) 631 (69.1) 499 (68.6) 87 (70.2) 298 (68.0)
LGA (BW<4000 g) 271 (2.0) 64 (2.5) 22 (2.4) 19 (2.6) 3 (2.4) 9 (2.0)
LGA (BW≥4000 g) 852 (6.4) 201 (7.9) 85 (9.3) 76 (10.4) 5 (4.0) 33 (7.5)
Missing 1653 (12.4) 298 (11.7) 103 (11.3) 84 (11.6) 15 (12.1) 54 (12.3)
  P 0.0175 0.0023 <0.0001 0.8489 0.9195

Birth weight (g)
≤ 2500 957 (7.2) 181 (7.1) 50 (5.5) 35 (4.8) 11 (8.9) 31 (7.1)
2501–3999 11068 (83.0) 2061 (80.8) 738 (80.8) 583 (80.2) 104 (83.9) 350 (79.9)
≥4000 1306 (9.8) 310 (12.5) 125 (13.7) 109 (15.0) 9 (7.2) 57 (13.0)
  P 0.0015 0.0002 <0.0001 0.5195 0.0848

Congenital malformation
No 13029 (97.7) 2464 (96.6) 875 (95.8) 704 (96.8) 112 (90.3) 426 (97.3)
Yes 115 (0.9) 54 (2.1) 23 (2.5) 10 (1.4) 10 (8.1) 6 (1.4)
Missing 187 (1.4) 34 (1.3) 15 (1.6) 13 (1.8) 2 (1.6) 6 (1.4)
  P <0.0001 <0.0001 0.2446 <0.0001 0.5341

Down syndrome
No 13326 (100.0) 2538 (99.4) 899 (98.5) 722 (99.3) 118 (95.2) 438(100)
Yes 5 (0.0) 14 (0.6) 14 (1.5) 5 (0.7) 6 (4.8)
  P <0.0001 <0.0001 <0.0001 <0.0001

SD, standard deviation; SGA, small for gestational age; AGA, appropriate for gestational age; LGA, large for gestational age; BW, birth weight;

a

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CNS, central nervous system tumors;

b

P-values derived from Chi-square and Fisher’s exact tests;

Number of cases and controls were calculated before exclusion of twins and triplets.